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IFG impaired fasting glucose IGT impaired glucose tolerance SNP single nucleotide polymorphism
To the Editor: Type 2 diabetes is a complex disease that has become a rapidly growing public health problem in China. The molecular mechanisms and underlying genetic architecture of type 2 diabetes still need to be clarified. Genomewide association studies have recently described novel type 2 diabetes susceptibility loci, including several previously unknown genomic regions, such as CDKAL1 and IGF2BP2 [1] [2] [3] [4] . Following these discoveries, a replication study has confirmed a significant association between type 2 diabetes and these two genes in the Japanese population [5] .
To investigate whether variations in CDKAL1 and IGF2BP2 also play a major role in type 2 diabetes susceptibility in China, we genotyped five representative variants (rs7754840, rs10946398 and rs7756992 in CDKAL1; rs4402960 and rs1470579 in IGF2BP2) in 4,189 Han Chinese participants, including 1,912 unrelated type 2 diabetic patients (785 men, 1,127 women; age 63.8±9 years), 236 individuals with impaired fasting glucose or impaired glucose tolerance (IFG/IGT; 83 men, 153 women; age 64±9 years) and 2,041 control individuals (635 men, 1,406 women; age 58±9 years). Diabetic and IFG/IGT participants were defined in accordance with WHO criteria. Controls with a fasting plasma glucose concentration of <6.1 mmol/l were enrolled from the same region. The clinical characteristics of the participants are summarised in Table 1 . The study protocol was reviewed and approved by the Ethics Committee of the Shanghai Institute for Biological Sciences and all participants gave informed consent. Highmolecular-weight genomic DNA was prepared from venous blood using the QuickGene 610L Automatic DNA/RNA Extraction System (Fijifilm, Tokyo, Japan). All five single nucleotide polymorphisms (SNPs) were genotyped using TaqMan technology on an ABI7900 system (Applied Biosystems, Foster City, CA, USA). Genotype data were obtained for more than 90% of the DNA samples and replicate quality control samples (32 samples) were genotyped with 100% concordance. The association of SNPs with type 2 diabetes was assessed by logistic regression after adjusting for sex, age and log e -transformed BMI (log e -BMI). For regression modelling in the additive model, individuals homozygous for the risk allele (1/1), heterozygous (1/0) and homozygous for the non-risk allele (0/0) were assigned a categorical variable according to genotype (2, 1 and 0, respectively). The dominant model was defined as 1/1 + 1/0 vs 0/0, and the recessive model as 1/1 vs 1/0 + 0/0. The statistical analyses were performed using SPSS statistical software (SPSS, Chicago, IL, USA). SHEsis was used to perform the Hardy-Weinberg equilibrium test and to compare differences in allele, genotype and haplotype frequencies between individuals with altered glucose metabolism and controls [6] . The population attributable risk was calculated as (X−1)/X, assuming the multiplicative model where
g is the estimated OR and f is the frequency of the risk allele [7] .
The genotype frequencies for the five SNPs are summarised in Table 2 and rs7756992 (OR=1.16, 95% CI 1.06-1.27, p=0.002), were significantly associated with type 2 diabetes in the Han Chinese population. However, the ORs (1.16-1.26) were slightly higher than those identified in studies of European populations (1.12-1.20) [1] [2] [3] [4] , which implies some ethnic differences between these studies and our own. The SNP rs7754840 showed the most significant association with diabetes in our study. When we tested the association between CDKAL1 rs7754840 and type 2 diabetes in a range of genetic models for our population, the most significant results were obtained in a recessive model that included age, sex and log e -BMI (CC vs GG/CG; OR 1.49, 95% CI 1.25-1.77, p=7.4×10
−6
). These results are consistent with studies on individuals of European descent and individuals from Hong Kong of Han Chinese ancestry [4] , which showed that the risk for individuals homozygous for the rs7756992 risk allele is much higher than for those who are heterozygous. Assuming a population frequency of 39.6% for the risk allele, C, as observed in our controls, the population attributable risk was 17.8% for rs7754840 in the Han Chinese population.
In our study, the SNPs rs4402960 and rs1470579 in IGF2BP2 were not associated with diabetes, but the ORs for the risk alleles were in the same direction as those in the Steinthorsdottir studies (rs4402960, T allele, OR 1.08; rs1470579, C allele, OR 1.03). We performed power calculations on the G*Power program [8] , which has a 77% power to detect an OR of 1.14 (according to the OR in IGF2BP2) and a p value of <0.01, so the absence of significant associations in our study may be due to a lack of power, mainly as a result of the limited sample number. It is important to note that the discrepancy might also be due to population-specific genetic backgrounds and environmental risk profiles.
Because the sample size of the IFG/IGT group was quite small we did not conduct a case-control comparison between this group and the control group, but the frequency of the risk allele in the IFG/IGT group was closer to that in the type 2 diabetic patient group than the control group.
In addition, we examined the association of these five SNPs with BMI, fasting plasma glucose, triacylglycerol, HbA 1c and WHR in the control group using multiple linear regression with BMI, fasting plasma glucose, triacylglycerol, HbA 1c and WHR as the dependent variables, genotype as the independent variable and sex, age and log e -BMI (except , respectively), and the associations were much stronger for genotypes homozygous for the risk alleles. The SNPs rs4402960 and rs1470579 in the IGF2BP2 region were associated with WHR (p=0.02 and p=0.03, respectively), but neither SNP showed an association with BMI, indicating that IGF2BP2 may affect adipose distribution.
In conclusion, we have identified a positive association between SNPs within CDKAL1 in the Han Chinese population. More comprehensive studies are needed into the associations of variations in CDKAL1 with functional correlates and type 2 diabetes risk in larger, ethnically diverse populations.
